EndoEvolution today claimed a win in its patent battle with JNJ subsidiary Ethicon over automated suturing technology. Raynham, Mass.-based EndoEvolution said the U.S. Patent & Trademark Office’s Patent Trial & Appeal Board denied Ethicon’s bid for an inter partes review of an EndoEvolution patent. Ethicon had challenged 30 claims in the EndoEvolution patent, the latter company […]
North Chelmsford, Mass.-based medical device startup EndoEvolution named a new chief executive as the company closed a $5 million funding round in support of new commercialization efforts.
Ron Rudowsky was appointed president & CEO of the automated suturing devices maker, taking the place of EndoEvolution founder Jerry Brecher, who will remain "closely involved" as the company heads to the market.
Semprus BioSciences Corp. won a $1 million grant to develop orthopedic devices resistant to biofilm formation for the U.S. Army’s Telemedicine & Advanced Technology Research Center.
Biofilms are the foundation for the most bacterial complications associated with implanted medical devices, according to a Semprus press release.